Avricore Health Inc. (TSXV:AVCR)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Sep 3, 2026, 1:40 PM EST
Avricore Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.19 | 0.53 | 4.79 | 3.49 | 1.77 | 0.12 | |
Revenue Growth | -93.73% | -88.84% | 37.32% | 97.08% | 1339.95% | 271.81% |
Cost of Revenue | 0.26 | 0.3 | 2.91 | 2.28 | 1.31 | 0.09 |
Gross Profit | -0.07 | 0.24 | 1.88 | 1.2 | 0.46 | 0.03 |
Selling, General & Admin | 1 | 1.19 | 1.16 | 1.08 | 0.77 | 0.93 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0.02 |
Operating Expenses | 1.1 | 1.46 | 1.7 | 1.79 | 1.11 | 1.45 |
Operating Income | -1.17 | -1.23 | 0.18 | -0.59 | -0.65 | -1.42 |
Interest Expense | - | - | - | - | - | -0.04 |
Interest & Investment Income | 0.01 | 0.01 | 0 | 0 | 0.01 | 0 |
Currency Exchange Gain (Loss) | -0 | -0 | -0.01 | -0.01 | 0 | -0 |
Other Non Operating Income (Expenses) | -0.04 | -0.04 | -0.05 | -0.11 | -0.17 | -0.33 |
EBT Excluding Unusual Items | -1.2 | -1.26 | 0.13 | -0.7 | -0.82 | -1.78 |
Gain (Loss) on Sale of Assets | - | - | -0.03 | - | - | - |
Asset Writedown | -0.49 | -0.49 | -0.77 | - | - | - |
Other Unusual Items | -0.11 | -0.11 | 0.01 | - | - | 0.08 |
Pretax Income | -1.8 | -1.86 | -0.67 | -0.7 | -0.82 | -1.71 |
Earnings From Continuing Operations | -1.8 | -1.86 | -0.67 | -0.7 | -0.82 | -1.71 |
Net Income | -1.8 | -1.86 | -0.67 | -0.7 | -0.82 | -1.71 |
Net Income to Common | -1.8 | -1.86 | -0.67 | -0.7 | -0.82 | -1.71 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 102 | 101 | 100 | 100 | 98 | 93 |
Shares Outstanding (Diluted) | 102 | 101 | 100 | 100 | 98 | 93 |
Shares Change | 1.19% | 0.97% | 0.76% | 1.74% | 5.67% | 53.20% |
EPS (Basic) | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
EPS (Diluted) | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.13 | -0.88 | 0.82 | -0.36 | -1.63 | -1.34 |
Free Cash Flow Per Share | -0.01 | -0.01 | 0.01 | -0.00 | -0.02 | -0.01 |
Gross Margin | -35.90% | 44.63% | 39.29% | 34.53% | 25.83% | 24.85% |
Operating Margin | -606.68% | -229.75% | 3.74% | -16.80% | -36.96% | -1153.22% |
Profit Margin | -933.80% | -348.16% | -13.98% | -20.12% | -46.27% | -1390.90% |
Free Cash Flow Margin | -583.90% | -164.54% | 17.21% | -10.36% | -92.24% | -1090.74% |
EBITDA | -1.11 | -1.1 | 0.62 | -0.17 | -0.47 | -1.4 |
EBITDA Margin | - | -206.30% | 12.90% | -4.75% | -26.61% | - |
D&A For EBITDA | 0.06 | 0.13 | 0.44 | 0.42 | 0.18 | 0.02 |
EBIT | -1.17 | -1.23 | 0.18 | -0.59 | -0.65 | -1.42 |
EBIT Margin | - | -229.75% | 3.74% | -16.80% | -36.96% | - |
Advertising Expenses | - | - | - | 0 | 0 | - |